Cafepharma Today

September 29 2016

Medtronic receives FDA approval for first-ever artificial pancreas, Novo Nordisk laying off 1000, Vertex Orkambi launch disappointment, and more - scroll down for the latest news

Wednesday's most active boards: Novo Nordisk, AstraZeneca, Novartis,

Wednesday's most active thread (Biogen): Layoff rumor

Should the government be involved in drug pricing? Come discuss on the CP group discussion board

click here for the latest message board posts
click here for the latest on pharma/biotech social media
click here for the latest on med device social media

Current News

FDA approves Medtronic's 'artificial pancreas' for diabetes
Reuters
Thursday, September 29, 2016 - 9:01am
tags:
FDA, Medtronic, artificial pancreas, type 1 diabetes, devices, MiniMed 670G
U.S. payer pressures force Novo Nordisk to cut loose 1,000 staffers
Fierce Pharma
Thursday, September 29, 2016 - 8:25am
tags:
Novo Nordisk, layoffs, R&D
Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field
Endpoints
Thursday, September 29, 2016 - 8:23am
tags:
Novartis, Amgen, CGRP blockers, migraines, erenumab
​Vertex confirms fears that latest drug launch is slower than hoped
Bizjournals.com
Thursday, September 29, 2016 - 8:19am
tags:
Vertex Pharmaceuticals, Orkambi, drug launch, cystic fibrosis
Amgen and Arrowhead to develop gene-therapies for heart disease
Yahoo/Reuters
Thursday, September 29, 2016 - 8:18am
tags:
Amgen, Arrowhead, R&D, gene therapy, heart disease
Gilead May Not Acquire Galapagos, For Now (GILD, GLPG)
Investopedia
Thursday, September 29, 2016 - 8:16am
tags:
Gilead Sciences, Galapagos
Most Americans believe prescription drug prices are unreasonable
Stat/Pharmalot
Thursday, September 29, 2016 - 8:15am
tags:
drug pricing
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thursday, September 29, 2016 - 8:14am
tags:
FDA, AbbVie, Amgen, biosimilars, Humira, Amjevita
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thursday, September 29, 2016 - 8:13am
tags:
Amgen, Kyprolis, clinical trials, Multiple Myeloma
Biogen Submits NDA for SMA Drug (BIIB, IONS)
Investopedia
Thursday, September 29, 2016 - 8:12am
tags:
Biogen, SMA, spinal muscular atrophy, Ionis Pharmaceuticals, Nusinersen
Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
Wednesday, September 28, 2016 - 10:40am
tags:
social media, Eli Lilly, JNJ, Boehringer Ingelheim, Novo Nordisk
GlaxoSmithKline Vaccines for Malaria, Zika Make It a Likely Winner
TheStreet.com
Wednesday, September 28, 2016 - 10:25am
tags:
GSK, vaccines, malaria, Zika virus
Big Pharma takes big lease in South S.F. to consolidate California operations
Bizjournals.com
Wednesday, September 28, 2016 - 10:23am
tags:
San Francisco, AstraZeneca
Novo Shows Its Devotion To Tresiba's Cause
Seeking Alpha
Wednesday, September 28, 2016 - 10:20am
tags:
Novo Nordisk, diabetes, insulin, Tresiba
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wednesday, September 28, 2016 - 10:18am
tags:
Shire, biosimilars, Humira, Enbrel, Momenta
Mylan, Lupin, others now in the mix for $1.1B Bayer derm buy
Fierce Pharma
Wednesday, September 28, 2016 - 10:17am
tags:
Mylan Labs, Lupin, Bayer, dermatology, M&A, Cadila, Torrent Pharmaceuticals
Pfizer Completes Acquisition of Medivation
Yahoo
Wednesday, September 28, 2016 - 10:16am
tags:
Pfizer, Medivation, M&A
Here's How To Punch Martin Shkreli In The Face
Forbes
Wednesday, September 28, 2016 - 10:15am
tags:
Martin Shkreli
From FDA expert to biotech insider: The drug industry thrives on the revolving door
Stat
Tuesday, September 27, 2016 - 10:17pm
tags:
FDA
Amgen's Osteoporosis Drug Crosses a Hurdle
Investopedia
Tuesday, September 27, 2016 - 10:14pm
tags:
Amgen, osteoporosis, romosozumab
3 Critical FDA Decisions You Can't Afford to Miss
Motley Fool
Tuesday, September 27, 2016 - 10:13pm
tags:
FDA, Orkambi, Vertex Pharmaceuticals, Roche, Tecentriq, Regeneron, Sanofi, Sarilumab
Eli Lilly: This is Gonna Be Good
Barron's
Tuesday, September 27, 2016 - 10:07pm
tags:
Eli Lilly, solanezumab, Alzheimer's disease
Incyte Could Be A Takeover Target, Argus Lifts Price Target To $98
Yahoo/Benzinga
Tuesday, September 27, 2016 - 10:04pm
tags:
Incyte, M&A
A Device Rep's Story of an Acquisition Gone Wrong (part 2 of 2)
CP Wire
Tuesday, September 27, 2016 - 12:13pm
tags:
devices, M&A, device reps
Sanofi grabs $43M in U.S. government funds to advance Zika vaccine into Phase II
Fierce Pharma
Tuesday, September 27, 2016 - 10:55am
tags:
Sanofi, Zika virus, vaccines, R&D
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Motley Fool
Tuesday, September 27, 2016 - 10:51am
tags:
Pfizer, Medivation, Xtandi, avelumab, Merck KGaA, Ibrance
Bristol-Myers to test Opdivo with Nektar drug for several cancers
Yahoo/Reuters
Tuesday, September 27, 2016 - 10:47am
tags:
Bristol-Myers Squibb, Opdivo, Nektar, NKTR-214, PD-1 inhibitors, cancer
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tuesday, September 27, 2016 - 10:18am
tags:
Amgen, Multiple Myeloma, Kyprolis, clinical trials, Takeda, Velcade
Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Forbes
Tuesday, September 27, 2016 - 10:15am
tags:
biotech, IPOs
For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million
TheStreet.com
Tuesday, September 27, 2016 - 10:14am
tags:
Pain Therapeutics, FDA, executive pay

Latest Pharmagather Articles

I Think We Should Have A Meeting to Discuss This
In the Pipeline
A Bucket of Photons
In the Pipeline
Right Hand, Left Hand, Either Hand
In the Pipeline
AZ at it again
Pharmagossip
Stakeholders Grapple with the Questions at Value Assessment Conference
pharmexec r&d
Alltrials Latest
Pharmagossip
What This Here Compound Needs Is Some Hydrogen Peroxide
In the Pipeline
NEW: The 2016–17 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels
New Drug Making Tech Could Bring Complex Biologics to Remote Populations
Digital Pharma Blog

Latest CP Wire Articles

When You Have To Sign a Non-Compete Agreement - Discussion With An Employment Attorney (part 1 of 2)
A Device Rep's Story of an Acquisition Gone Wrong (part 2 of 2)
A Device Rep's Story of an Acquisition Gone Wrong (part 1 of 2)
GSK Hires First Female CEO of a Global Pharma Co - What Employees Think
One Company's Employees Say an Acquisition Was Mishandled
UroToday.com, Leading Urology Reference Site, Launches New Publication: Everyday Urology-Oncology Insights
Older Rep Seeking New Job - Advice From the Field
When Things Go Wrong With Your Job - Interview With an Employment Attorney, Part two
When Things Go Wrong With Your Job - Interview With an Employment Attorney, Part One
5 Secrets to Landing Your Dream Job

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Arbutus Reports Interim Multi-Dose Results from Phase II Clinical Trial of ARB-1467 in Patients with Chronic HBV Infection
Thursday, September 29, 2016 - 4:01pm
AB Science announces the filing of masitinib in the treatment of amyotrophic lateral sclerosis (ALS) to the European Medicines Agency
Thursday, September 29, 2016 - 12:03pm
Cell Design Labs Announces Peer-Reviewed Publication Validating Ability to Program Immune Cells to Treat Cancer and Autoimmune Disease
Thursday, September 29, 2016 - 12:00pm
Ginkgo Bioworks and Genomatica Forge Alliance to Accelerate Commercialization of More Sustainable High-Volume Chemicals
Thursday, September 29, 2016 - 9:00am
Novamont opens world’s first commercial plant for bio-production of a major intermediate chemical
Thursday, September 29, 2016 - 9:00am
Intuitive Surgical and Fosun Pharma Establish Joint Venture to Research, Develop, Manufacture and Sell Lung Cancer Diagnostic and Therapeutic Tools in China
Thursday, September 29, 2016 - 8:54am
Fibrocell to Present at 2016 Cell & Gene Meeting on the Mesa
Thursday, September 29, 2016 - 8:00am
Cytokinetics Announces Early Termination of Hart-Scott-Rodino Waiting Period for Expanded Collaboration With Astellas
Thursday, September 29, 2016 - 7:30am
Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexor’s Potential in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
Thursday, September 29, 2016 - 7:30am
Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
Thursday, September 29, 2016 - 7:05am

Breaking Healthcare News - powered by Seeking Alpha

Threshold Pharmaceuticals -67.8% as cancer studies fail goals
Thursday, September 29, 2016 - 6:53pm
Aurinia's voclosporin successful in mid-stage study in lupus nephritis; shares ahead 14% after hours
Thursday, September 29, 2016 - 6:50pm
Delcath readies equity offering
Thursday, September 29, 2016 - 6:23pm
ERBA unable to meet deadline to regain compliance with listing requirements, faces delisting
Thursday, September 29, 2016 - 4:35pm
ImmunoGen to cut 17% of workforce after strategic review; shares off 4% after hours
Thursday, September 29, 2016 - 4:21pm
InspireMD to reverse split shares 1:25; post-split trading commences October 10
Thursday, September 29, 2016 - 3:37pm
Healthcare - Top 5 Gainers / Losers as of 11:00 am
Thursday, September 29, 2016 - 11:00am
CSL Behring's long-acting hemophilia B treatment Idelvion approved in Japan
Thursday, September 29, 2016 - 10:39am
FDA places Alcobra's MDX program on clinical hold due to adverse effects; shares down 57%
Thursday, September 29, 2016 - 10:16am
Edwards' INSPIRIS RESILIA valve receives CE mark
Thursday, September 29, 2016 - 9:43am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Latest social media